Table 1.
Study | Virus coinfected | Mono-infection | Co-infection | Notes |
---|---|---|---|---|
De Paulis, 2011 [23] |
Any viruses |
8 (6-10) |
8 (6-12) |
Median (IQR) |
Espinola, 2012 [18] |
Any viruses |
2-12 |
2-15 |
Range |
Falkenstein-Hagander, 2014 [41] |
Any viruses |
5.0 (3.0-6.0) |
3.0 (3.0-5.0) |
Median (IQR) |
Gagliardi, 2013 [19] |
Any viruses |
8 |
8 |
Median |
Gokce, 2018 [26] |
Any viruses |
7.2 ± 3.8 |
7.5 ± 4.7 |
Mean±SD |
Janahi, 2017 [27] |
Any viruses |
81% |
88% |
Proportion of ≥4 d of stay |
Kelly, 2015 [28] |
Any viruses |
5.1(2.1-8.0) |
4.0(2.1-9.0) |
Median (IQR) |
Mansbach, 2012 [20] |
Any viruses |
48% |
51% |
Proportion of ≥3 d of stay |
Petrarca, 2018 [33] |
Any viruses |
5 (1-27) |
5 (2-12) |
Median (range) |
Yu, 2010 [37] |
Any viruses |
7.2 ± 3.6 |
7.2 ± 2.0 |
Mean±SD |
Aberle, 2005 [21] |
RV |
7.6 ± 0.3 |
7.4 ± 0.4 |
Mean±SEM |
de Silva, 2013 [7] |
RV |
6.1* in 0-5m, 5.9* in 6m-3y |
10.8 ± 3.4 in 0-5m, 5.6 ± 0.5 in 6m-3y |
Mean±SD |
Janahi, 2017 [27] |
RV |
81% |
84% |
Proportion of ≥4 d of stay |
Kwon, 2019 [38] |
RV |
5 (2-12) |
4 (3-13) |
Median (range) |
Mansbach, 2012 [20] |
RV |
48% |
54% |
Proportion of ≥3 d of stay |
Marguet, 2009 [32] |
RV |
6 (5-8) |
5 (4-6) |
Median (IQR) |
Petrarca, 2018 [33] |
RV |
5 (1-27) |
5 (3-9) |
Median (range) |
Janahi, 2017 [27] |
Any viruses minus RV |
81% |
91% |
Proportion of ≥4 d of stay |
Mansbach, 2012 [20] |
Any viruses minus RV |
48% |
47% |
Proportion of ≥3 d of stay |
Ali, 2010 [22] |
hMPV |
4 (3-6.2) |
8.5 (4-9.7) |
Median (IQR) |
Caracciolo, 2008 [40] |
hMPV |
3.5 ± 3.0 |
4.1 ± 2.1 |
Mean±SD |
Foulongne, 2006 [24] |
hMPV |
4 (2-5) |
7 (4-8) |
Median (IQR) |
Aberle, 2005 [21] | ADV | 7.6 ± 0.3 | 7.8 ± 0.9 | Mean±SEM |
RV – rhinovirus, hMPV – human metapneumovirus, ADV – adenovirus, IQR – interquartile range, SD – standard deviation, SEM – standard error of the mean, m – month, y – year
*Standard deviation was not available.